Serum Uric Acid (Uric Acid)
Uric acid is the final heterocyclic oxidation product of purine nucleotide metabolism catalyzed by xanthine oxidase. Intracellular hyperuricemia induces mitochondrial oxidative stress and blunts endothelial nitric oxide production.
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
3.5 - 7.2 mg/dL (Male), 2.6 - 6.0 mg/dL (Female)
General reference distribution across unselected commercial populations.
3.5 - 5.0 mg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Xanthine oxidase converts hypoxanthine to xanthine, then to uric acid with the generation of superoxide free radicals. Elevated intracellular uric acid activates the pro-inflammatory NLRP3 inflammasome.
Differential Diagnosis
Elevated Levels (Uric Acid High)
- •Gout / Urate nephropathy
- •Metabolic syndrome and high dietary fructose consumption
- •Renal clearance insufficiency (URAT1 overactivation)
- •Tumor lysis syndrome
Low Levels (Uric Acid Low)
- •Wilson disease (renal tubular Fanconi syndrome)
- •Xanthine oxidase deficiency / High-dose allopurinol
- •Low purine diet / Protein restriction
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Maintain standard hydration status prior to venipuncture; acute hypovolemia or hemoconcentration artificially elevates concentrations. Avoid heavy resistance training and high-protein meals (especially cooked red meat) for 24 hours prior if testing serum creatinine. Ensure tourniquet time does not exceed 60 seconds to avoid pseudohyperkalemia or hemoconcentration of electrolyte fractions.
Reflexive Testing Protocol:
- Simultaneous Serum Cystatin C testing to calculate composite CKD-EPI Creatinine-Cystatin C eGFR equation
- Spot Urine Albumin-to-Creatinine Ratio (uACR) to detect subclinical glomerular endothelial leak
- Renal duplex ultrasonography to assess bilateral kidney dimensions, cortical echogenicity, and resistive index
- Fractional Excretion of Sodium (FENa) and Urea (FEUrea) to differentiate prerenal azotemia from intrinsic acute kidney injury
- Serum and urine protein electrophoresis (SPEP/UPEP) if tubular injury or monoclonal gammopathy is suspected
Clinical Citations & Primary Literature (1)
- [1]Uric Acid in Metabolic Syndrome and Cardiovascular Disease - Nature Reviews Cardiology (2022). PMID: 34997194
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Uric Acid (Uric Acid) into overall healthspan optimization.